A Multicenter, Randomized, Masked, Controlled Study to Evaluate Retisert, and Intravitreal Fluocinolone Acetonide Implant, in the Treatment of Patients With Diabetic Macular Edema
Phase of Trial: Phase II/III
Latest Information Update: 27 Nov 2013
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 01 Aug 2011 Results published in Ophthalmology.
- 01 Aug 2011 Primary endpoint 'Visual-acuity' has been met (3059668).
- 16 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History